Allison Fiscalini
Director, Athena Breast Prog.
Surgery
School of Medicine

Education & Training

Show all (2) Hide

• MPH Health Services, Social and Behavioral Sciences University of Washington 6/2008
• BS Psychology, Psychobiology Santa Clara University 6/2005

Interests

Show all (1) Hide

• breast cancer

Websites

Show all (1) Hide

• The WISDOM Study (thewisdomstudy.org)

Grants and Projects

Show all (2) Hide

• Extending the Diversity, Reach, and Generalizability of the WISDOM Study, National Cancer Institute (NCI), 2020-2025
• Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer, Patient Centered Outcomes Research Institute, 2015-2022

Publications (21)

Top publication keywords:
Genetic Predisposition to DiseaseTissue ExpansionGenetic TestingHematologic NeoplasmsMammographyAnxietyEarly Detection of CancerHematopoietic Stem Cell TransplantationBreast NeoplasmsProblem SolvingPrecision MedicineMastectomy, SubcutaneousMultifactorial InheritanceGerm-Line MutationCarcinoma, Intraductal, Noninfiltrating

• Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.
  JAMA oncology 2026 Shieh Y, Heise RS, Madlensky L, Sabacan LP, Soto IA, Fiscalini AS, Ross K, Goodman D, Blanco A, Brain S, Heditsian DM, Moya J, Fergus KB, Olopade OI, Scheuner MT, Eklund M, Ziv E, Tice JA, van 't Veer…
• WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.
  NPJ breast cancer 2026 Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL,…
• Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
  JAMA 2026 Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, …
• Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.
  JAMA internal medicine 2026 Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, …
• Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network.
  Breast cancer research and treatment 2026 Leggat-Barr K, Lewis T, Tice JA, Tsopurashvili E, Sayaman R, Warner P, Malvin K, Sabacan L, Perry-Solomon A, Theiner S, Acerbi I, Griffin A, McGuire J, Lee V, Borowsky AD, Wisdom Study and Athena …

Show all (16 more) Hide

• WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.
  Research square 2025 Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL,…
• Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.
  Genome medicine 2025 Fergus KB, Heise RS, Madlensky L, Fiscalini A, Sabacan L, Theiner S, Kapoor S, Soto IA, Blanco A, Ross K, Goodman-Gruen D, Scheuner M, Hu D, Heditsian D, Brain S, Arasu VA, Kaster A, Chapa L, Olopade …
• Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational Study.
  JMIR cancer 2024 Baxter-King R, Naeim A, Huang TQ, Sepucha K, Stanton A, Rudkin A, Ryu R, Sabacan L, Vavreck L, Esserman L, Stover Fiscalini A, Wenger NS
• Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.
  NPJ breast cancer 2024 Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ
• Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study.
  Public health genomics 2024 Riddle L, James JE, Naeim A, Madlensky L, Brain S, DeRosa D, Eklund M, Fiscalini AS, Heditsian D, Koenig B, Ross K, Sabacan LP, Tong B, Wenger N, Joseph G
• Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study.
  Research square 2023 Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ
• Correction to: Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.
  Journal of cancer survivorship : research and practice 2022 Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL
• The WISDOM study: a new approach to screening can and should be tested.
  Breast cancer research and treatment 2021 Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L,…
• Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.
  NPJ breast cancer 2021 Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ, Athena Breast …
• Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial.
  NPJ breast cancer 2021 Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman LJ
• Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.
  Journal of cancer survivorship : research and practice 2021 Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL
• Response to Carter et al.
  JNCI cancer spectrum 2020 Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ
• Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, Romano E, Romano JM, Martin PJ, Yi JC
• An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation.
  Journal of cancer survivorship : research and practice 2018 Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM
• Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes.
  Annals of surgical oncology 2014 Wang F, Peled AW, Garwood E, Fiscalini AS, Sbitany H, Foster RD, Alvarado M, Ewing C, Hwang ES, Esserman LJ
• Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction.
  Annals of plastic surgery 2014 Peled AW, Duralde E, Foster RD, Fiscalini AS, Esserman LJ, Hwang ES, Sbitany H